CORCEPT THERAPEUTICS INC
CORT
84 insider filings · Latest: Oct 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Jun 18 8:30 PM | David L MahoneyDirector | Sale | 20,000 | $84.53 | $1.7M | 26,147(I) | View → |
| Jun 15, 2026 | Jun 17 8:30 PM | Atabak MokariChief Financial Officer | Sale | 40,000 | $81.15 | $3.2M | 16,130(D) | View → |
| Jun 16, 2026 | Jun 16 7:06 PM | MAHONEY DAVID L | Proposed Sale | 20,000 | $83.34 | $1.7M | — | View → |
| Jun 16, 2026 | Jun 16 5:55 PM | WILSON JAMES N | Proposed Sale | 30,000 | $83.20 | $2.5M | — | View → |
| Jun 2, 2026 | Jun 4 8:49 PM | William GuyerChief Development Officer | Sale | 20,000 | $70.60 | $1.4M | 3,985(D) | View → |
| Jun 1, 2026 | Jun 3 11:20 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 25,000 | $70.21 | $1.8M | 8,977(D) | View → |
| Jun 1, 2026 | Jun 3 11:20 PM | Atabak MokariChief Financial Officer | Sale | 40,000 | $70.00 | $2.8M | 15,257(D) | View → |
| Jun 1, 2026 | Jun 2 8:05 PM | BELANOFF JOSEPH KDirector, Chief Executive Officer | Sale | 12,837 | $69.74 | $895.3K | 2,565,489(I) | View → |
| Jun 2, 2026 | Jun 2 6:25 PM | Guyer William | Proposed Sale | 20,000 | $70.44 | $1.4M | — | View → |
| Jun 1, 2026 | Jun 1 9:50 PM | Mokari Atabak | Proposed Sale | 160,000 | $70.00 | $11.2M | — | View → |
| Jun 1, 2026 | Jun 1 3:40 PM | BELANOFF JOSEPH K | Proposed Sale | 12,837 | $69.49 | $892.0K | — | View → |
| May 27, 2026 | May 29 10:11 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Sale | 5,000 | $65.00 | $325.0K | 6,230(D) | View → |
| May 27, 2026 | May 29 10:03 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Sale | 75,000 | $65.59 | $4.9M | 8,977(D) | View → |
| May 27, 2026 | May 27 10:07 PM | Maduck Sean | Proposed Sale | 150,000 | $65.59 | $9.8M | — | View → |
| May 20, 2026 | May 20 4:46 PM | Lyon Joseph Douglas | Proposed Sale | 5,000 | $58.22 | $291.1K | — | View → |
| May 5, 2026 | May 7 8:30 PM | William GuyerChief Development Officer | Sale | 20,000 | $51.83 | $1.0M | 2,231(D) | View → |
| May 1, 2026 | May 5 8:30 PM | BELANOFF JOSEPH KDirector, Chief Executive Officer | Sale | 40,000 | $50.10 | $2.0M | 2,878,326(I) | View → |
| May 5, 2026 | May 5 3:13 PM | Guyer William | Proposed Sale | 20,000 | $51.60 | $1.0M | — | View → |
| May 1, 2026 | May 1 4:30 PM | BELANOFF JOSEPH K | Proposed Sale | 40,000 | $46.52 | $1.9M | — | View → |
| Apr 7, 2026 | Apr 8 11:34 PM | William GuyerChief Development Officer | Sale | 20,000 | $40.97 | $819.4K | 2,231(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Oct 5 11:58 PM | Roberto Wandenkolk VieiraPresident, Oncology | Option Exercise | 8,333 | $21.63 | 133,334(D) | View → |
| Oct 2, 2026 | Oct 5 11:54 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Option Exercise | 9,190 | $19.26 | 44,167(D) | View → |
| Oct 1, 2026 | Oct 5 11:54 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Option Exercise | 810 | $13.56 | 3,357(D) | View → |
| Oct 2, 2026 | Oct 5 11:49 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 24,587 | $8.27 | 41,986(D) | View → |
| Oct 1, 2026 | Oct 5 11:49 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 413 | $8.27 | 66,573(D) | View → |
| Oct 1, 2026 | Oct 5 11:44 PM | Justin Frederick GunnPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Grant/Award | 100,000 | $114.03 | 100,000(D) | View → |
| Sep 17, 2026 | Sep 18 11:47 PM | Gary Charles RobbChief Business Officer | Option Exercise | 17,493 | $8.27 | 182,507(D) | View → |
| Sep 14, 2026 | Sep 16 8:30 PM | Joseph Douglas LyonChief Accounting & Technology Officer | Option Exercise | 10,000 | $13.56 | 4,167(D) | View → |
| Sep 1, 2026 | Sep 4 1:16 AM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 25,000 | $8.27 | 66,986(D) | View → |
| Sep 2, 2026 | Sep 4 1:02 AM | Roberto Wandenkolk VieiraPresident, Oncology | Option Exercise | 58,333 | $21.63 | 141,667(D) | View → |
| Aug 26, 2026 | Aug 28 8:30 PM | Kimberly ParkDirector | Option Exercise | 30,000 | $13.49 | 30,000(D) | View → |
| Aug 25, 2026 | Aug 27 8:30 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 30,955 | $11.35 | 169,045(D) | View → |
| Aug 14, 2026 | Aug 18 8:30 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 3,664 | $8.27 | 91,986(D) | View → |
| Aug 10, 2026 | Aug 12 8:27 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 1,031 | $8.27 | 95,650(D) | View → |
| Aug 10, 2026 | Aug 12 8:26 PM | William GuyerChief Development Officer | Option Exercise | 16,300 | $21.65 | 110,000(D) | View → |
| Aug 4, 2026 | Aug 6 10:44 PM | William GuyerChief Development Officer | Option Exercise | 3,700 | $21.65 | 126,300(D) | View → |
| Aug 3, 2026 | Aug 5 9:51 PM | Sean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission. | Option Exercise | 20,305 | $8.27 | 96,681(D) | View → |
| Jul 30, 2026 | Aug 3 8:30 PM | Atabak MokariChief Financial Officer | Option Exercise | 80,000 | $23.06 | 95,833(D) | View → |
| Jul 15, 2026 | Jul 17 10:31 PM | Atabak MokariChief Financial Officer | Option Exercise | 40,000 | $23.06 | 175,833(D) | View → |
| Jul 7, 2026 | Jul 8 11:54 PM | William GuyerChief Development Officer | Option Exercise | 20,000 | $21.65 | 130,000(D) | View → |
Page 1 of 3
Next →